Medline (MDLN) Payables (2024 - 2026)

Medline (MDLN) has 3 years of Payables data on file, last reported at $932.0 million in Q1 2026.

• On a quarterly basis, Payables changed N/A year-over-year to $932.0 million in Q1 2026; TTM through Mar 2026 was $932.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $961.0 million, up 10.59% from the prior year.
• Payables for Q1 2026 stood at $932.0 million, down from $961.0 million in the prior quarter.
• Over the last five years, Payables for MDLN reached as high as $961.0 million in Q4 2025 and fell as low as $869.0 million in Q4 2024.
• Historically, Payables has averaged $920.7 million across 3 years, with a median of $932.0 million in 2026.
• On a YoY basis, Payables climbed as much as 10.59% in 2025 and fell as far as 10.59% in 2025.
• Year by year, Payables stood at $869.0 million in 2024, then rose by 10.59% to $961.0 million in 2025, then decreased by 3.02% to $932.0 million in 2026.
• Per Business Quant data, the three most recent Payables figures were $932.0 million in Q1 2026, $961.0 million in Q4 2025, and $869.0 million in Q4 2024.